Nautilus Biotechnology, Inc. (NAUT:NASDAQ) closed at $2.06 on October 16, 2026, down 4.63% on the day. The stock trades 52.2% below its 52-week high of $4.31 and 144.9% above its 52-week low of $0.841. Over the past year, it gained 112.4%. Nautilus Biotechnology, Inc. is part of the Health Care sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -5.07% | +111.93% | +21.89% | -30.41% | +112.37% |
In 252 trading sessions since October 16, 2025, NAUT closed higher on 113 days (45%). Its best day was November 3, 2025 (+39.10%) and its worst was July 28, 2026 (-27.71%). The stock moved 10% or more in a single session 36 times. It opened at least 5% above the previous day's high 2 times.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.
Find more stocks like NAUT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.